CBAN — COLONY BANKCORP INC

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying CBAN?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
50
Institutional Conviction
Net distribution · 1 buying vs 1 selling last quarter
34
Macro Tailwind
Macro conditions are a headwind for this sector
38
Why? — Evidence & Confidence ▾

Of 2 tracked investors who changed their CBAN position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).

Supporting evidence
  • +1 tracked investor added or increased positions last quarter (Izzy Englander)
  • +3 tracked investors reported holding CBAN at their latest filing
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
  • −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.

About COLONY BANKCORP INC (CBAN)

COLONY BANKCORP INC (CBAN) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $6M. Across recent filings, tracked investors recorded 4 new positions, 2 increased, 1 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CBAN

75
/100
Institutional Accumulation
Added / Increased6
Reduced1
Exited1
BearishBullish
Crowded Trade Score™

How many top investors track CBAN

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

CBAN Ownership Composition

How COLONY BANKCORP INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
100% of tracked value
Institutions
3
tracked investors
Total Reported
$7M
combined 13F value
Types1
  • Multi-Strategy / Quant100.0%
Multi-Strategy / Quant(3)
100.0%

Tracked investors currently reporting CBAN

  • Ken GriffinSep 30, 2026
    Citadel Advisors
    Shares
    287.6K
    Value
    $5.8M
    % Portfolio
    0.00%
  • Steve CohenSep 30, 2026
    Point72 Asset Management
    Shares
    18.4K
    Value
    $369.6K
    % Portfolio
    0.00%
  • Izzy EnglanderSep 30, 2026
    Millennium Management
    Shares
    40.9K
    Value
    $823.2K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold CBAN?
3 tracked institutional investors disclosed a position in CBAN (COLONY BANKCORP INC) in their most recent 13F filing.
Who is the largest institutional holder of CBAN?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in CBAN, valued at $6M.
Did institutional ownership of CBAN increase or decrease?
Across recent 13F filings, tracked investors recorded 4 new positions, 2 increased, 1 reduced, and 1 fully exited CBAN.
Where does this CBAN ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.